Organogenesis Inc. is a regenerative medicine company with the unique skill set to take complex, living therapies from research and development (R&D), through manufacturing, to successful commercialization to reach patients today. As a pioneer in the field of regenerative medicine, Organogenesis received the first FDA approval of a living, allogeneic, cell based product (Apligraf®, approved for the treatment of venous leg ulcers). Apligraf is now the leading regenerative medicine product in the world, with two FDA-approved indications. In 2012 we received an FDA approval for GINTUIT™, a living, human cell-based product that represents a new therapeutic class in dentistry.

Sernova Corp., a health sciences company, focuses on the development and commercialization of medical technologies in the United States and Canada. Its proprietary platform technologies include Cell Pouch System, a device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. The company also focuses to commercialize products for the treatment of Parkinson’s, spinal cord injury, and haemophilia diseases. Sernova Corp. is headquartered in London, Canada.

Geistlich Pharma AG researches, manufactures and provides pharmaceutical products, gelatine products, biomaterials and industrial glues. It offers Geistlich Bio-Oss and Geistlich Bio-Gide products. The firm specializes in biomaterials for the regeneration of bone, cartilage and tissue and develops, and manufactures medical devices. The company was founded in 1851 and is headquartered in Wolhusen, Switzerland.

Ed Geistlich S��hne AG F��r Chemische Industrie is a multi-national private company headquartered in Schlieren, Switzerland. The firm operates as holding company.

Part of Dentsply Sirona, Inc., Datum Dental Ltd. is an Israeli company located in Lod. The firm sells dental products through online. It was founded in 2012 by Yuval Zubery, Arie Goldlust and Itay Itzhaky. Itay Itzhaky has been the CEO since the inception date. Dentsply Sirona, Inc. acquired Datum Dental Ltd. on January 21, 2021 for $31.51 million.

Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

Seattle-based biotechnology company focused on targeting cancer to transform lives through the discovery, development and commercialization of novel therapeutics to fight cancer. Dendreon applies its expertise in antigen identification, engineering and cell processing to produce Active Cellular Immunotherapy (ACI) product candidates designed to stimulate an immune response. ACI holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. In addition to ACI product candidates, the company is also developing an orally-available small molecule targeting TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia.

Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ.

Biocean Novatech, Inc. is a Canadian company located in Windsor, QC. The firm operates as a medical laboratory. It was founded in 2001.

Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative "firsts," Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, and nephrology. With the same unwavering passion for new challenges, They dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.

The Texas A&M University System creates a seamless pathway for students to earn an associate and bachelor’s degree in related fields

Crossing SRL develops applications of the active cross-linking. It produces non-toxic leather, active packaging, antimicrobial building materials, and active cellulose. The company was founded by Valentina Beghetto and is headquartered in Treviso, Italy.

MedSkin Solutions Dr. Suwelack AG engages in research to utilize biological modes of action for use in medical care, aesthetic care and professional skin care. The firm offers MatriDerm and ProHeal products. The firm offers solution's for med and advanced wound care, tissue regeneration and haemostasis. The company was founded in 1997 and is headquartered in Billerbeck, Germany.

NIPPI is a manufacturing company that develops aircraft components, target systems, rocket components, space equipment, and aircraft repair.

Innocoll Pharmaceuticals Ltd. engages in pharmaceutical preparations. The company was founded on June 1, 2005 and is headquartered in Dublin, Ireland.